Supernus Pharmaceuticals (SUPN) Posts Exciting Clinical Data Regarding Trokendi XR™ and Oxtellar XR™ on the Company Website
12/13/2013 9:27:41 AM
ROCKVILLE, Md., Dec. 12, 2013 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, today announced that the clinical data that was released at the American Epilepsy Society (AES) Meeting in December in Washington DC is now available on its website. Please click here to view.
Help employers find you! Check out all the jobs and post your resume.
comments powered by